Founded Year
1996Stage
Asset Sale | AssetsPurchasedTotal Raised
$55.19MAbout Cardion
Developer of novel therapeutics for applications in the treatment of inflammatory and autoimmune disorders, as well as related disease conditions. These include rheumatoid arthritis, Crohn's disease, diabetes, transplant rejection, as well as targeted therapies of immune-system cell cancers such as multiple myeloma. These include rheumatoid arthritis, Crohn's disease, diabetes, and transplant rejection, as well as targeted therapies of immune-system cell cancers such as multiple myeloma. The company is focusing on three rapidly growing product fields: a novel immunotherapeutic protein for the treatment of Rheumatoid Arthritis and other Inflammatory diseases; gene and protein therapy for the ischemic cardiovascular disease and congestive heart failure (CHF); and stem cell therapy for the treatment of Type I diabetes and CHF. The company integrates stem cell-technology, tolerance induction, and non-viral local gene therapy to support a balanced pipeline of product candidates in the cardiovascular and autoimmunity franchise.
Cardion Headquarter Location
Max-Planck-Strasse 15a
Erkrath, 40699,
Germany
49 211 20565 0
Expert Collections containing Cardion
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Cardion is included in 2 Expert Collections, including Diabetes.
Diabetes
1,750 items
Regenerative Medicine
1,818 items
Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).
Cardion Patents
Cardion has filed 1 patent.
The 3 most popular patent topics include:
- Cardiac arrhythmia
- Cardiac electrophysiology
- Cardiac procedures
Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
11/25/2020 | Cardiac arrhythmia, Cardiac electrophysiology, Cardiology, Cardiac procedures, Heart diseases | Application |
Application Date | 11/25/2020 |
---|---|
Grant Date | |
Title | |
Related Topics | Cardiac arrhythmia, Cardiac electrophysiology, Cardiology, Cardiac procedures, Heart diseases |
Status | Application |
Latest Cardion News
Feb 24, 2022
| Technavio News provided by Share this article Share this article NEW YORK, Feb. 24, 2022 /PRNewswire/ -- The latest Implantable Loop Recorders Market research report by Technavio infers that the growing number of cardiac conditions due to irregularity in heart rhythms and other chronic diseases is driving this market's growth. Resulting in market growth of USD 606.31 million from 2021 to 2026, read additional information about the market, get FREE sample report . Attractive Opportunities in Implantable Loop Recorders Market by Application and Geography - Forecast and Analysis 2022-2026 Vendor Landscape The market structure is expected to remain fragmented during the forecast period. Vendors are deploying different organic and inorganic growth strategies to compete in the market. Abbott Laboratories, Angel Medical Systems Inc., Asian Heart and Vascular Centre, BIOTRONIK SE and Co. KG, Boston Scientific Corp., CARDION sro, Medtronic Plc, TechIndia Infoway Pvt. Ltd., Vectorious Medical Technologies Ltd. among others are some of the few key vendors competing to maintain their market position in the market. Various players in the market are engaging in strategic partnerships and joint ventures coupled with launching differentiated products to up their game in the medical technology and device industry. For instance, in January 2020, CardioComm Solutions Inc. entered into a partnership agreement with CareOS SAS, a subsidiary of Baracoda Group, to provide consumer ECG monitoring technologies through the CareOS Poseidon smart mirror health and beauty hub. View more about the market's vendor landscape highlights with a comprehensive list of vendors and their offerings. Key Market Segmentation Regional Market Outlook North America will contribute to 39% of the market growth during the forecast period. The growth of this region can be attributed to the increase in the prevalence of cardiovascular diseases, coronary artery disease, peripheral artery disease, and stroke. Apart from regions, if we look at the country-wise market growth, the US, Canada, Spain, Denmark, China, and UK will contribute to the highest market growth. Download our FREE sample report for more key highlights on the regional market share of most of the above-mentioned countries. Latest Trends, Driving the Global Home Textile Retail Market Market Driver: Growing number of cardiac conditions due to irregularity in heart rhythms: Every year, approximately 209,000 patients in the United States are treated for in-hospital cardiac arrest, according to the Centers for Disease Control and Prevention (CDC). Arrhythmia can be exacerbated by other illnesses such as chronic liver and renal disease, as well as thyroid problems. According to the CDC, chronic kidney disease affects over 15% of adults in the United States, or nearly 37 million individuals (CKD). Every hour, roughly 340 people receive dialysis therapy for kidney failure, according to the CDC. The majority of ESRD patients who get hemodialysis suffer from cardiac arrest and arrhythmia. As a result, rising demand for arrhythmia monitoring devices like ILR is expected to drive market expansion throughout the forecast period. Market Trend: The supportive government and non-government initiative: Governments all across the world are concerned about the rise in cardiovascular disease cases. Furthermore, half of the world's population resides in rural areas, and nations like Spain, China, Thailand, and India are focusing on improving access to healthcare in these areas. As a result, the medical technology and device business is collaborating with government and non-governmental organizations to address the worrying state of people's health. Find additional information about various other market drivers & trends mentioned in our FREE sample report . Want to understand more about the various research methodology? Evaluate a specific segment or region in detail Identify key suppliers, customers, or other market players Analyze market regulations Tailor this report according to your needs. Get it done with our $1000 worth of free customization. Speak to Our Analyst Now ! Related Reports: 4.2 Bargaining power of buyers Exhibit 16: Bargaining power of buyers 4.3 Bargaining power of suppliers Exhibit 17: Bargaining power of suppliers 4.4 Threat of new entrants Exhibit 18: Threat of new entrants 4.5 Threat of substitutes 4.6 Threat of rivalry 4.7 Market condition 5 Market Segmentation by Application 5.1 Market segments 5.2 Comparison by Application 5.3 Cardiac arrhythmia - Market size and forecast 2021-2026 Exhibit 24: Cardiac arrhythmia - Market size and forecast 2021-2026 ($ million) Exhibit 25: Cardiac arrhythmia - Year-over-year growth 2021-2026 (%) 5.4 Atrial fibrillation - Market size and forecast 2021-2026 Exhibit 26: Atrial fibrillation - Market size and forecast 2021-2026 ($ million) Exhibit 27: Atrial fibrillation - Year-over-year growth 2021-2026 (%) 5.5 Market opportunity by Application Exhibit 28: Market opportunity by Application 6. Customer landscape 6.1 Overview Technavio's customer landscape matrix comparing Drivers or price sensitivity, Adoption lifecycle, importance in customer price basket, Adoption rate and Key purchase criteria Exhibit 29: Customer landscape Exhibit 32: North America - Market size and forecast 2021-2026 ($ million) Exhibit 33: North America - Year-over-year growth 2021-2026 (%) 7.4 Europe - Market size and forecast 2021-2026 Exhibit 34: Europe - Market size and forecast 2021-2026 ($ million) Exhibit 35: Europe - Year-over-year growth 2021-2026 (%) 7.5 Asia - Market size and forecast 2021-2026 Exhibit 36: Asia - Market size and forecast 2021-2026 ($ million) Exhibit 37: Asia - Year-over-year growth 2021-2026 (%) 7.6 ROW - Market size and forecast 2021-2026 Exhibit 38: ROW - Market size and forecast 2021-2026 ($ million) Exhibit 39: ROW - Year-over-year growth 2021-2026 (%) 7.7 Key leading countries 7.8 Market opportunity by geography Exhibit 41: Market opportunity by geography 8. Drivers, Challenges, and Trends 8.1 Market drivers 8.1.2 Growing awareness initiatives and access to healthcare 8.1.3 Technological advances and new product launches 8.2 Market challenges Exhibit 47: Market positioning of vendors 10.3 Abbott Laboratories Exhibit 49: Abbott Laboratories - Business segments Exhibit 50: Abbott Laboratories - Key News Exhibit 51: Abbott Laboratories - Key offerings Exhibit 52: Abbott Laboratories - Segment focus 10.4 Angel Medical Systems Inc. Exhibit 53: Angel Medical Systems Inc. - Overview Exhibit 54: Angel Medical Systems Inc. - Product and service Exhibit 55: Angel Medical Systems Inc. - Key offerings 10.5 Asian Heart and Vascular Centre Exhibit 56: Asian Heart and Vascular Centre - Overview Exhibit 57: Asian Heart and Vascular Centre - Product and service Exhibit 58: Asian Heart and Vascular Centre - Key offerings 10.6 BIOTRONIK SE and Co. KG Exhibit 59: BIOTRONIK SE and Co. KG - Overview Exhibit 60: BIOTRONIK SE and Co. KG - Product and service Exhibit 61: BIOTRONIK SE and Co. KG - Key offerings 10.7 Boston Scientific Corp. Exhibit 63: Boston Scientific Corp. - Business segments Exhibit 64: Boston Scientific Corp. - Key News Exhibit 65: Boston Scientific Corp. - Key offerings Exhibit 66: Boston Scientific Corp. - Segment focus 10.8 CARDION sro Exhibit 68: CARDION sro - Product and service Exhibit 69: CARDION sro - Key offerings 10.9 Medtronic Plc Exhibit 71: Medtronic Plc - Business segments Exhibit 72: Medtronic Plc - Key offerings Exhibit 73: Medtronic Plc - Segment focus 10.10 TechIndia Infoway Pvt. Ltd. Exhibit 74: TechIndia Infoway Pvt. Ltd. - Overview Exhibit 75: TechIndia Infoway Pvt. Ltd. - Product and service Exhibit 76: TechIndia Infoway Pvt. Ltd. - Key offerings 10.11 Vectorious Medical Technologies Ltd. Exhibit 77: Vectorious Medical Technologies Ltd. - Overview Exhibit 78: Vectorious Medical Technologies Ltd. - Product and service Exhibit 79: Vectorious Medical Technologies Ltd. - Key offerings 11. Appendix 11.1.1 Market definition About Us Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios. Contact
When was Cardion founded?
Cardion was founded in 1996.
Where is Cardion's headquarters?
Cardion's headquarters is located at Max-Planck-Strasse 15a, Erkrath.
What is Cardion's latest funding round?
Cardion's latest funding round is Asset Sale.
How much did Cardion raise?
Cardion raised a total of $55.19M.
Who are the investors of Cardion?
Investors of Cardion include Roche Venture Fund, TVM Capital Life Science, IKB Private Equity, Deutsche Venture Capital, BDW and 9 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.